1. Home
  2. IMAB vs ABAT Comparison

IMAB vs ABAT Comparison

Compare IMAB & ABAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • ABAT
  • Stock Information
  • Founded
  • IMAB 2014
  • ABAT 2011
  • Country
  • IMAB United States
  • ABAT United States
  • Employees
  • IMAB N/A
  • ABAT N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • ABAT Metal Mining
  • Sector
  • IMAB Health Care
  • ABAT Basic Materials
  • Exchange
  • IMAB Nasdaq
  • ABAT Nasdaq
  • Market Cap
  • IMAB 394.2M
  • ABAT 1.1B
  • IPO Year
  • IMAB 2020
  • ABAT N/A
  • Fundamental
  • Price
  • IMAB $4.66
  • ABAT $5.50
  • Analyst Decision
  • IMAB Strong Buy
  • ABAT
  • Analyst Count
  • IMAB 6
  • ABAT 0
  • Target Price
  • IMAB $7.50
  • ABAT N/A
  • AVG Volume (30 Days)
  • IMAB 2.1M
  • ABAT 25.1M
  • Earning Date
  • IMAB 11-14-2025
  • ABAT 11-14-2025
  • Dividend Yield
  • IMAB N/A
  • ABAT N/A
  • EPS Growth
  • IMAB N/A
  • ABAT N/A
  • EPS
  • IMAB N/A
  • ABAT N/A
  • Revenue
  • IMAB N/A
  • ABAT $4,290,224.00
  • Revenue This Year
  • IMAB N/A
  • ABAT $951.86
  • Revenue Next Year
  • IMAB N/A
  • ABAT N/A
  • P/E Ratio
  • IMAB N/A
  • ABAT N/A
  • Revenue Growth
  • IMAB N/A
  • ABAT 1148.97
  • 52 Week Low
  • IMAB $0.60
  • ABAT $0.73
  • 52 Week High
  • IMAB $6.79
  • ABAT $11.49
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 48.67
  • ABAT 49.83
  • Support Level
  • IMAB $4.86
  • ABAT $4.76
  • Resistance Level
  • IMAB $6.79
  • ABAT $7.04
  • Average True Range (ATR)
  • IMAB 0.71
  • ABAT 1.28
  • MACD
  • IMAB -0.02
  • ABAT -0.24
  • Stochastic Oscillator
  • IMAB 25.27
  • ABAT 11.71

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About ABAT American Battery Technology Company

American Battery Technology Co is an integrated critical battery minerals company that develops technologies for both primary battery minerals manufacturing and lithium-ion battery recycling. It operates battery recycling facilities that process materials from electric vehicle batteries, stationary battery energy storage systems, and consumer electronics. Additionally, the company advances lithium production projects using proprietary technology to produce battery-grade lithium hydroxide. It generates revenue mainly from its recycling operations and is expanding capacity with strategic partnerships and government grants. The company's activities focus on creating a closed-loop battery materials supply chain to support sustainable manufacturing in the United States.

Share on Social Networks: